From Ace 2 to Brain: Patterns, Correlations, Severity and Diversity of COVID-19 Symptoms among a Cohort of Patients

Author(s): Muamar M. A. Shaheen* and Manar A. J. Al-Junaidi

Abstract

Background: Angiotensin II enzyme (ACE 2) was extensively investigated in SARS-CoV-2 as the viral entrance. The abundance, distribution and diversity of this enzyme dictate the wide range of symptoms patients suffer from during the acute phase of COVID-19 infection and determine late phase symptoms.

Objective: To determine factors associated with diversity of COVID-19 symptoms and relationship of these symptoms to each other. Design and methods: This is a retrospective cohort study that involved 191 Polymerase Chain Reaction (PCR) positive COVID-19 patients who were symptomatic while home quarantined between March 2020 and January 2021 in Hebron district, southern West Bank. A well prepared questionnaire was used to gather clinical data and information about symptoms patients suffered from during the acute phase of infection.

Results: 191 symptomatic PCR positive COVID-19 subjects were included in this study. They were 31.4 ± 16.4 years old and 59.2% females. Using Fisher`s exact test, there was a strong relationship between anorexia and loss of either taste, smell, or both or not losing any of them, p=0.002. Suffering from Gastrointestinal (GIT) symptoms; such as diarrhea, nausea, vomiting, or combination of them was associated with anorexia, p=0.002. We found a significant relationship between specific GIT symptoms and dizziness, or headache; p=0.00, for each one. There was a strong relationship between having any of the GIT symptoms and agues, or headache, p=0.045 and 0.000, respectively, on Pearson Chisquare test. There was also a relationship between gender and headache, p=0.002.

Conclusion: Local or systemic GI symptoms, neurological symptoms (headache, dizziness) along with smell and taste are connected to each other via gut brain axis or micro biota gut brain axis

Share this article